NON-HODGKINS LYMPHOMA
Clinical trials for NON-HODGKINS LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new NON-HODGKINS LYMPHOMA trials appear
Sign up with your email to follow new studies for NON-HODGKINS LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy shows promise for Tough-to-Treat lymphoma
Disease control OngoingThis study tests a combination of drugs (glofitamab, atezolizumab or polatuzumab vedotin, plus a single pre-treatment dose of obinutuzumab) in adults with B-cell non-Hodgkin's lymphoma that has come back or not responded to prior treatment. The goal is to find the safest dose and…
Matched conditions: NON-HODGKINS LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
New hope for lymphoma: drug cocktail targets Tough-to-Treat cancers
Disease control OngoingThis study is for Japanese adults with Non-Hodgkin lymphoma, a type of blood cancer. Researchers are testing a drug called tafasitamab, alone or combined with other medicines (lenalidomide, parsaclisib, or R-CHOP chemotherapy), to see if it is safe and helps shrink tumors. The st…
Matched conditions: NON-HODGKINS LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Incyte Biosciences Japan GK • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
Scientists seek blood cancer samples to unlock new treatments
Knowledge-focused ENROLLING_BY_INVITATIONThis study collects blood and bone marrow samples from 550 people with blood cancers like leukemia and lymphoma. Researchers will study the samples in the lab to learn more about how these cancers work and find new ways to treat them. Participants give samples during their regula…
Matched conditions: NON-HODGKINS LYMPHOMA
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 26, 2026 11:16 UTC